| Reduced lung-cancer mortality with volume CT screening in a randomized trial HJ de Koning, CM van Der Aalst, PA de Jong, ET Scholten, K Nackaerts, ... New England journal of medicine 382 (6), 503-513, 2020 | 2519 | 2020 |
| Management of lung nodules detected by volume CT scanning RJ van Klaveren, M Oudkerk, M Prokop, ET Scholten, K Nackaerts, ... New England Journal of Medicine 361 (23), 2221-2229, 2009 | 983 | 2009 |
| Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening N Horeweg, J van Rosmalen, MA Heuvelmans, CM van der Aalst, ... The Lancet Oncology 15 (12), 1332-1341, 2014 | 548 | 2014 |
| Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers N Horeweg, ET Scholten, PA de Jong, CM van der Aalst, C Weenink, ... The Lancet Oncology 15 (12), 1342-1350, 2014 | 408 | 2014 |
| PL02. 05 effects of volume CT lung cancer screening: mortality results of the NELSON randomised-controlled population based trial H De Koning, C Van Der Aalst, K Ten Haaf, M Oudkerk Journal of Thoracic Oncology 13 (10), S185, 2018 | 319 | 2018 |
| Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial N Horeweg, CM Van Der Aalst, E Thunnissen, K Nackaerts, C Weenink, ... American journal of respiratory and critical care medicine 187 (8), 848-854, 2013 | 296 | 2013 |
| Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval U Yousaf-Khan, C van der Aalst, PA de Jong, M Heuvelmans, E Scholten, ... Thorax 72 (1), 48-56, 2017 | 287 | 2017 |
| Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial N Horeweg, CM van der Aalst, R Vliegenthart, Y Zhao, X Xie, ET Scholten, ... European Respiratory Journal 42 (6), 1659-1667, 2013 | 249 | 2013 |
| Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial JE Walter, MA Heuvelmans, PA de Jong, R Vliegenthart, PMA van Ooijen, ... The Lancet Oncology 17 (7), 907-916, 2016 | 236 | 2016 |
| Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch–Belgian randomised controlled lung cancer screening trial CM van der Aalst, KAM van den Bergh, MC Willemsen, HJ de Koning, ... Thorax 65 (7), 600-605, 2010 | 202 | 2010 |
| Performance and cost-effectiveness of computed tomography lung cancer screening scenarios in a population-based setting: a microsimulation modeling analysis in Ontario, Canada K Ten Haaf, MC Tammemägi, SJ Bondy, CM van der Aalst, S Gu, ... PLoS medicine 14 (2), e1002225, 2017 | 150 | 2017 |
| Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules? ET Scholten, PA de Jong, B de Hoop, R van Klaveren, ... European Respiratory Journal 45 (3), 765-773, 2015 | 123 | 2015 |
| The impact of a lung cancer computed tomography screening result on smoking abstinence CM van der Aalst, RJ van Klaveren, KAM van den Bergh, MC Willemsen, ... European Respiratory Journal 37 (6), 1466-1473, 2011 | 112 | 2011 |
| Lung cancer screening: latest developments and unanswered questions CM van der Aalst, K Ten Haaf, HJ de Koning The Lancet Respiratory Medicine 4 (9), 749-761, 2016 | 93 | 2016 |
| Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study MA Heuvelmans, JE Walter, RB Peters, GH de Bock, U Yousaf-Khan, ... Lung Cancer 113, 45-50, 2017 | 88 | 2017 |
| Diagnosis of chronic obstructive pulmonary disease in lung cancer screening computed tomography scans: independent contribution of emphysema, air trapping and bronchial wall … OM Mets, M Schmidt, CF Buckens, MJ Gondrie, I Isgum, M Oudkerk, ... Respiratory research 14, 1-8, 2013 | 84 | 2013 |
| The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial CM van der Aalst, HJ de Koning, KAM van den Bergh, MC Willemsen, ... Lung cancer 76 (2), 204-210, 2012 | 83 | 2012 |
| Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial CM van der Aalst, SJAM Denissen, M Vonder, JWC Gratama, ... European Heart Journal-Cardiovascular Imaging 21 (11), 1216-1224, 2020 | 70 | 2020 |
| Recommendations for implementing lung cancer screening with low-dose computed tomography in Europe G Veronesi, DR Baldwin, CI Henschke, S Ghislandi, S Iavicoli, M Oudkerk, ... Cancers 12 (6), 1672, 2020 | 67 | 2020 |
| Risk stratification based on screening history: the NELSON lung cancer screening study U Yousaf-Khan, C Van Der Aalst, PA De Jong, M Heuvelmans, E Scholten, ... Thorax 72 (9), 819-824, 2017 | 66 | 2017 |
